Axovant Announces Clinical Updates from AXO-AAV-GM2 and AXO-Lenti-PD Studies

Go back to Axovant Announces Clinical Updates from AXO-AAV-GM2 and AXO-Lenti-PD Studies
(NASDAQ: AXGT) Delayed: 2.10 --0 (-0%)
Previous Close $2.10    52 Week High
Open $3.11    52 Week Low
Day High $2.10    P/E N/A 
Day Low $2.10    EPS
Volume